Onestream Inc(OS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OS Onestream Inc

盘前交易 07-09 04:18:38 EDT

26.13

-0.34

-1.28%

最高26.91	最低25.96	成交量128.34万
今开26.64	昨收26.47	日振幅3.60%
总市值46.06亿	流通市值18.24亿	总股本1.76亿
成交额3,362万	换手率1.84%	流通股本6,981万
市净率11.15	ROE-108.78%	每股收益-1.77
52周最高35.39	52周最低16.69	市盈率-14.79
股息0.00	股息收益率0.00	ROA-35.83%

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OS","market":"US","secType":"STK","nameCN":"Onestream Inc","latestPrice":26.13,"timestamp":1752004800000,"preClose":26.47,"halted":0,"volume":1283368,"delay":0,"floatShares":69811845,"shares":176260091,"eps":-1.766751,"marketStatus":"盘前交易","change":-0.34,"latestTime":"07-09 04:18:38 EDT","open":26.64,"high":26.9126,"low":25.96,"amount":33622432.05112,"amplitude":0.035988,"askPrice":29.27,"askSize":100,"bidPrice":23.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.766751,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752067800000},"marketStatusCode":1,"adr":0,"listingDate":1721793600000,"exchange":"NASDAQ","adjPreClose":26.13,"postHourTrading":{"tag":"盘后","latestPrice":26.66,"preClose":26.13,"latestTime":"19:57 EDT","volume":155261,"amount":4057260.24,"timestamp":1752019076282},"volumeRatio":0.5851604877200206,"impliedVol":0.6436,"impliedVolPercentile":0.6809},"requestUrl":"/m/hq/s/OS","defaultTab":"news","newsList":[{"id":"2550520979","title":"Os Therapies Incorporated盘中异动 急速跳水6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550520979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550520979?lang=zh_cn&edition=full","pubTime":"2025-07-09 02:55","pubTimestamp":1752000957,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日02时55分，Os Therapies Incorporated股票出现异动，股价快速下挫6.84%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Zyversa Therapeutics, Inc.、湖岸生物、Seastar Medical Holding Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为4137.58%、632.66%、349.51%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为146.75%、73.81%、70.96%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709025557a69daad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709025557a69daad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","OSTX","BK4097","BK4139"],"gpt_icon":0},{"id":"2549558629","title":"Os Therapies Incorporated盘中异动 股价大跌5.46%报1.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558629?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:44","pubTimestamp":1751895870,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时44分，Os Therapies Incorporated股票出现波动，股价快速跳水5.46%。截至发稿，该股报1.73美元/股，成交量19.0751万股，换手率0.63%，振幅4.37%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.60%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507072144309539a04d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507072144309539a04d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4139","OSTX","BK4097"],"gpt_icon":0},{"id":"2548394331","title":"【基石药业-B(02616.HK)公布Nofazinlimab治疗肝细胞癌的国际多中心 III期研究的最新进展】智通财经","url":"https://stock-news.laohu8.com/highlight/detail?id=2548394331","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548394331?lang=zh_cn&edition=full","pubTime":"2025-07-04 22:34","pubTimestamp":1751639654,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","LU1169590202.USD","BK4097","BK4195","BK7095","ORR.AU","BK4134","BK4211","ORR","PD","OS","LU1169589451.USD","PFS","BK4023","HCC","BK4006","02616","III","BK1574"],"gpt_icon":0},{"id":"2547654018","title":"Os Therapies Incorporated盘中异动 早盘大幅拉升5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547654018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547654018?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:47","pubTimestamp":1751291265,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时47分，Os Therapies Incorporated股票出现波动，股价快速上涨5.43%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2370.48%、140.53%、78.46%，振幅较大的相关个股有Artelo Biosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Eyenovia, Inc.，振幅分别为79.51%、34.23%、26.93%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021474595315558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021474595315558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","BK4139","OS","BK4097"],"gpt_icon":0},{"id":"2546756989","title":"Onestream, Inc.盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546756989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546756989?lang=zh_cn&edition=full","pubTime":"2025-06-27 02:55","pubTimestamp":1750964127,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日02时55分，Onestream, Inc.股票出现异动，股价急速拉升5.01%。Onestream, Inc.股票所在的软件服务行业中，整体涨幅为0.72%。其相关个股中，Cyngn Inc.、Core Scientific Inc C/Wts 23/01/2027 、Webull Corporation C/Wts 10/04/2029 涨幅较大，Cyngn Inc.、Jet.AI、Urgent.Ly Inc.较为活跃，换手率分别为7237.79%、66.19%、47.49%，振幅较大的相关个股有Cyngn Inc.、Real Messenger Corp C/Wts 19/11/2029、Core Scientific Inc C/Wts 23/01/2027 ，振幅分别为575.25%、67.32%、66.72%。Onestream, Inc.公司简介：OneStream Inc 是一个支持人工智能且可扩展的软件平台，能够在单一平台上统一核心财务功能以及更广泛的运营数据和流程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627025527979041bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627025527979041bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","OS"],"gpt_icon":0},{"id":"2546924612","title":"Os Therapies Incorporated盘中异动 急速拉升8.14%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546924612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546924612?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:41","pubTimestamp":1750858902,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时41分，Os Therapies Incorporated股票出现异动，股价急速上涨8.14%。截至发稿，该股报1.86美元/股，成交量2.6538万股，换手率0.09%，振幅2.04%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.60%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142a4bd7354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142a4bd7354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","OS","BK4097","BK4139"],"gpt_icon":0},{"id":"2545285869","title":"【复宏汉霖(02696.HK)：汉斯状®(斯鲁利单抗注射液)联合化疗一线治疗广泛期小细胞肺癌(ES-SCLC)的日本桥接","url":"https://stock-news.laohu8.com/highlight/detail?id=2545285869","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545285869?lang=zh_cn&edition=full","pubTime":"2025-06-24 18:04","pubTimestamp":1750759445,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159883","IE00B29SXL02.USD","BK1574","BK1222","BK4097","OS","BK4585","BK4588","LU2637428348.USD","BK1100","BK1161","IE00BMG7P926.USD","IE00B29SXK94.USD","LU2449327464.USD","IE00BMG7P819.SGD","IE00BMG7P694.USD","BK1583","LU1880398471.USD","09996","IE00BMG7P587.USD","03347","IE00BMQBXF63.USD","LU1880398554.USD","LU1883839398.USD","BK1576","02696","BK4081","09997","LU1803068623.USD","ES","IE00BZ18W340.USD","IE00BZ18W456.USD","BK1141"],"gpt_icon":0},{"id":"2545288941","title":"复宏汉霖：汉斯状联合化疗一线治疗ES-SCLC日本桥接试验完成首例患者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2545288941","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545288941?lang=zh_cn&edition=full","pubTime":"2025-06-24 17:52","pubTimestamp":1750758765,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BZ18W340.USD","BK4097","IE00BMG7P819.SGD","BK1141","IE00BMG7P694.USD","IE00BMG7P926.USD","IE00BZ18W456.USD","02696","IE00BMQBXF63.USD","BK1576","LU2449327464.USD","BK1583","BK1161","IE00B29SXK94.USD","LU2637428348.USD","LU1880398471.USD","BK4585","03347","LU1883839398.USD","OS","ES","LU1880398554.USD","IE00B29SXL02.USD","LU1803068623.USD","BK4081","IE00BMG7P587.USD","BK4588"],"gpt_icon":0},{"id":"2545449870","title":"Onestream, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545449870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545449870?lang=zh_cn&edition=full","pubTime":"2025-06-24 00:33","pubTimestamp":1750696433,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日00时33分，Onestream, Inc.股票出现波动，股价快速跳水5.00%。截至发稿，该股报26.39美元/股，成交量56.7111万股，换手率0.32%，振幅5.40%。Onestream, Inc.股票所在的软件服务行业中，整体涨幅为0.36%。其相关个股中，Currenc Group Inc.、Alpha Modus Holdings, Inc.、移动财经涨幅较大，Currenc Group Inc.、Wag!Onestream, Inc.公司简介：OneStream Inc 是一个支持人工智能且可扩展的软件平台，能够在单一平台上统一核心财务功能以及更广泛的运营数据和流程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003353a4b987dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003353a4b987dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097"],"gpt_icon":0},{"id":"2544166696","title":"艾伯维Bcl-2抑制剂VERONA折戟","url":"https://stock-news.laohu8.com/highlight/detail?id=2544166696","media":"CPHI制药在线","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544166696?lang=zh_cn&edition=full","pubTime":"2025-06-19 18:15","pubTimestamp":1750328104,"startTime":"0","endTime":"0","summary":"关注并星标CPHI制药在线Bcl-2抑制剂“水土不服”2025年6月16日，艾伯维宣布Bcl-2抑制剂维奈克拉联合阿扎胞苷一线治疗高危骨髓增生异常综合征的三期临床VERONA宣告失败。这种异质性导致不同患者对Bcl-2抑制剂的敏感性不同，使得药物难以对所有患者都产生理想疗效。Bcl-2抑制剂作用于白血病细胞的凋亡通路，但骨髓基质细胞的保护作用削弱了其疗效，使得白血病细胞难以被有效清除。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619190433a4b27962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619190433a4b27962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3B42.SGD","LU1934455863.HKD","LU2089283258.USD","SG9999011175.SGD","LU1989771016.USD","BK4585","LU0158827948.USD","LU0949170772.SGD","ORR","LU2129689431.USD","IE00BGHQF631.EUR","LU0211327993.USD","BK4550","BK4581","LU1267930573.SGD","IE00B19Z3581.USD","LU1057294990.SGD","LU0320765646.SGD","LU0203345920.USD","CR","BK4161","LU0965509283.SGD","LU2468319806.SGD","LU1003077747.HKD","LU2087621335.USD","LU0310799852.SGD","LU0417517546.SGD","OS","LU1989772923.USD","LU0128525929.USD","LU0456855351.SGD","IE00BVYPNV92.GBP","SG9999003800.SGD","LU0234570918.USD","LU1929549753.HKD","TLS","ABBV","SG9999015945.SGD","IE00BDGV0183.EUR","LU0965509101.SGD","HR","LU1074936037.SGD","LU2129689514.USD","LU1244550577.SGD","IE00BFTCPJ56.SGD","LU1496350171.SGD","LU1732800096.USD","LU0689472784.USD","LU1244550221.USD"],"gpt_icon":0},{"id":"2544181398","title":"【基石药业-B(02616.HK)：舒格利单抗GEMSTONE-302长期生存数据再登《柳叶刀•肿瘤学》】智通财经APP","url":"https://stock-news.laohu8.com/highlight/detail?id=2544181398","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544181398?lang=zh_cn&edition=full","pubTime":"2025-06-19 08:15","pubTimestamp":1750292155,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","OS","02616","BK4195","BK4211","PFS","BK1161","BK4134","BK4097","III"],"gpt_icon":0},{"id":"2544373918","title":"Os Therapies Incorporated盘中异动 股价大跌5.79%报1.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544373918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544373918?lang=zh_cn&edition=full","pubTime":"2025-06-18 04:15","pubTimestamp":1750191335,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日04时15分，Os Therapies Incorporated股票出现波动，股价快速下挫5.79%。截至发稿，该股报1.79美元/股，成交量22.2987万股，换手率0.79%，振幅6.32%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为1.71%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506180415359520a2de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506180415359520a2de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OS","OSTX"],"gpt_icon":0},{"id":"2543263323","title":"Os Therapies Incorporated盘中异动 股价大跌5.16%报1.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543263323","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543263323?lang=zh_cn&edition=full","pubTime":"2025-06-13 22:40","pubTimestamp":1749825650,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日22时40分，Os Therapies Incorporated股票出现异动，股价快速跳水5.16%。截至发稿，该股报1.75美元/股，成交量8.7732万股，换手率0.31%，振幅6.52%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为0.49%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613224050977e5aa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613224050977e5aa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097","BK4139","OSTX"],"gpt_icon":0},{"id":"2542384995","title":"Os Therapies Incorporated盘中异动 早盘大幅跳水5.61%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542384995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542384995?lang=zh_cn&edition=full","pubTime":"2025-06-11 21:57","pubTimestamp":1749650258,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日21时57分，Os Therapies Incorporated股票出现波动，股价急速下跌5.61%。截至发稿，该股报1.85美元/股，成交量5.4093万股，换手率0.19%，振幅3.57%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.14%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112157389517efa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506112157389517efa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OS","OSTX"],"gpt_icon":0},{"id":"2542333711","title":"Os Therapies Incorporated盘中异动 早盘股价大涨5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542333711","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542333711?lang=zh_cn&edition=full","pubTime":"2025-06-09 22:09","pubTimestamp":1749478199,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日22时09分，Os Therapies Incorporated股票出现波动，股价急速拉升5.69%。截至发稿，该股报1.77美元/股，成交量5.4583万股，换手率0.19%，振幅3.05%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.48%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609220959a700ba69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609220959a700ba69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OSTX","OS","BK4097","BK4139"],"gpt_icon":0},{"id":"2541665074","title":"Os Therapies Incorporated盘中异动 早盘大幅跳水6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541665074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541665074?lang=zh_cn&edition=full","pubTime":"2025-06-05 23:19","pubTimestamp":1749136791,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日23时19分，Os Therapies Incorporated股票出现异动，股价急速下跌6.63%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、Immatics N V C/Wts 01/07/2025 、Liminatus Pharma, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Nucana Plc、Eyenovia, Inc.较为活跃，换手率分别为1806.54%、568.56%、189.49%，振幅较大的相关个股有Liminatus Pharma Inc C/Wts 30/04/2030 、Scinai Immunotherapeutics Ltd、Liminatus Pharma, Inc.，振幅分别为140.64%、126.98%、75.39%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605231951a6fbf27c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605231951a6fbf27c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OS","BK4097","OSTX","BK4139"],"gpt_icon":0},{"id":"2539275624","title":"Os Therapies Incorporated盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539275624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539275624?lang=zh_cn&edition=full","pubTime":"2025-05-30 22:23","pubTimestamp":1748615012,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日22时23分，Os Therapies Incorporated股票出现异动，股价快速下跌5.06%。截至发稿，该股报1.50美元/股，成交量1.6605万股，换手率0.06%，振幅4.43%。Os Therapies Incorporated股票所在的生物技术行业中，整体跌幅为3.85%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053022233295085aea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053022233295085aea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4097","OS","OSTX"],"gpt_icon":0},{"id":"2538211551","title":"艾伯维挥起拳头","url":"https://stock-news.laohu8.com/highlight/detail?id=2538211551","media":"新康界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538211551?lang=zh_cn&edition=full","pubTime":"2025-05-25 10:59","pubTimestamp":1748141979,"startTime":"0","endTime":"0","summary":"艾伯维，作为昔日药王的拥有者，面临专利悬崖压境，举起拳头挥向新战场！表1.艾伯维免疫领域核心产品这一颓势直接拖累艾伯维2024年净利润下跌12.03%。表2.艾伯维肿瘤领域核心产品然而，随着百济神州的泽布替尼、阿斯利康的阿卡替尼等二代BTK抑制剂通过“头对头”试验证明更优疗效与安全性，伊布替尼市场份额被快速瓜分。02频繁动刀为了走出“泥潭”，艾伯维在肿瘤领域多次挥刀，转而瞄准自免与神经科学等赛道。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525114119a48b5df4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250525114119a48b5df4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","IE00BGHQF631.EUR","IBD","IE00BDGV0183.EUR","LU0203347892.USD","LU0234572021.USD","LU0310800379.SGD","LU1585245621.USD","LU1934455863.HKD","LU1983299246.USD","LU2087621335.USD","SG9999015945.SGD","IE00B4R5TH58.HKD","LU1244550221.USD","SG9999003800.SGD","LU0912757837.SGD","LU2237443382.USD","LU0965509101.SGD","IE00B19Z3B42.SGD","LU1551013425.SGD","SG9999015986.USD","ABBV","IE00BVYPNV92.GBP","LU0861579265.USD","IE0002270589.USD","LU1093756325.SGD","LU0949170772.SGD","LU2129689605.HKD","ORR","BK4093","LU2237443895.HKD","LU2112291526.USD","OS","LU0122379950.USD","LU1244550577.SGD","LU0211327993.USD","PFS","SG9999015952.SGD","LU0820561909.HKD","BK4566","CF","IE0009355771.USD","LU0029864427.USD","LU1162221912.USD","LU1244550494.USD","IE00B3PB1722.GBP","LU1989772923.USD","PROC","LU2133065610.SGD","BK4139"],"gpt_icon":0},{"id":"2537153585","title":"Os Therapies Incorporated盘中异动 急速拉升5.10%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537153585","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537153585?lang=zh_cn&edition=full","pubTime":"2025-05-23 23:17","pubTimestamp":1748013455,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日23时17分，Os Therapies Incorporated股票出现异动，股价大幅上涨5.10%。截至发稿，该股报1.61美元/股，成交量6.3982万股，换手率0.23%，振幅6.54%。Os Therapies Incorporated股票所在的生物技术行业中，整体涨幅为0.00%。Os Therapies Incorporated公司简介：OS Therapies Inc 是一家临床阶段的生物制药公司，专注于骨肉瘤和其他实体肿瘤治疗的鉴定、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052323173597636406&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052323173597636406&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4097","BK4139","OS","OSTX"],"gpt_icon":0},{"id":"2537976421","title":"科济药业舒瑞基奥仑赛注射液（CT041）的摘要已公布于ASCO网站","url":"https://stock-news.laohu8.com/highlight/detail?id=2537976421","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537976421?lang=zh_cn&edition=full","pubTime":"2025-05-23 08:00","pubTimestamp":1747958400,"startTime":"0","endTime":"0","summary":"关于舒瑞基奥仑赛注射液舒瑞基奥仑赛注射液是一款潜在全球同类首创的、靶向Claudin18.2蛋白的自体CAR-T细胞治疗候选产品，用于治疗Claudin18.2阳性实体瘤，主要治疗胃癌/食管胃结合部腺癌及胰腺癌。2020年9月，舒瑞基奥仑赛注射液被美国FDA授予\"孤儿药\"认定用于治疗胃癌/食管胃结合部腺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4694213_ZH94213_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4195","IE00B66KJ199.SGD","LU2065731478.USD","CRS","BK1585","BK4006","BK1574","BK4213","TPC","BK4022","BK4097","IE0031619046.USD","SOC","BK1587","CAR","BK4230","IE00B7SZL793.SGD","BK1161","02171","PFS","IE00B19Z4B17.USD","OS","BK4211","BK4129"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onestream.com","stockEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":-0.0965},{"period":"3month","weight":0.284},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.3065},{"period":"ytd","weight":-0.0838}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"OneStream, Inc.于2021年10月15日在特拉华州注册成立。OneStream提供了一个统一的、支持人工智能和可扩展的软件平台——数字金融云，使首席财务官办公室现代化并增加其战略影响力。他们的平台将核心财务和更广泛的运营数据和流程统一在一个平台内，其解决方案保持了公司财务报告标准的完整性，同时为业务用户提供了重要的运营见解。通过专门为财务构建的嵌入式应用人工智能和机器学习技术，他们的平台自动化和简化了工作流程，加速了分析并提高了预测准确性，使首席财务官办公室能够报告、预测和指导业务绩效。","exchange":"NASDAQ","name":"Onestream Inc","nameEN":"Onestream Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Onestream Inc(OS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Onestream Inc(OS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Onestream Inc,OS,Onestream Inc股票,Onestream Inc股票老虎,Onestream Inc股票老虎国际,Onestream Inc行情,Onestream Inc股票行情,Onestream Inc股价,Onestream Inc股市,Onestream Inc股票价格,Onestream Inc股票交易,Onestream Inc股票购买,Onestream Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Onestream Inc(OS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Onestream Inc(OS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况